Marie‐Hélène Laverrière

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung

Nathalie Stürm, Sylvie Lantuéjoul, Marie‐Hélène Laverrière et al. · Human Pathology · 2001 · 177 citations

Endocrine Oncology, Thyroid Disease, Pathology +9

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

Laurent Villeneuve, Arnaud Thivolet, Naoual Bakrin et al. · European Journal of Surgical Oncology · 2016 · 64 citations

Surgical Oncology, Peritoneal Malignancy Extent, Gastrointestinal Oncology +10

Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series

Sylvain Bernard, Raphaële Germi, Julien Lupo et al. · Clinical Microbiology and Infection · 2015 · 53 citations

Viral Diagnostics, Immunodeficiencies, Immunology +9

Primary adrenocortical sarcomatoid carcinoma: case report and review of literature

Nathalie Stürm, Nabila Moulaï, Marie‐Hélène Laverrière et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2007 · 37 citations

Neuro-oncology, Adrenal Gland, Adrenal Disease +2

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

Séverine Valmary‐Degano, Prudence Colpart, Laurent Villeneuve et al. · European Journal of Surgical Oncology · 2017 · 26 citations · Full text